ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Aug 21, 2026 · Director, President & CIO Sukhatme Mayukh sold 335.17K Common Shares at $36.88/unit ($12.4M); exercised options for 670.35K shares

Director, President & CIO Sukhatme Mayukh sold 335.17K Common Shares at $36.88/unit ($12.4M); exercised options for 670.35K shares

FORM 4

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).